US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

NGNE

Neurogene (NGNE)

Neurogene Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NGNE

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	20 : 30	Business Wire	Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates	NASDAQ:NGNE	Neurogene Inc
2024/05/07	19 : 19	Business Wire	Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome during ASGCT Annual Meeting	NASDAQ:NGNE	Neurogene Inc
2024/04/23	05 : 36	Business Wire	Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting	NASDAQ:NGNE	Neurogene Inc
2024/03/19	05 : 14	Business Wire	Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates	NASDAQ:NGNE	Neurogene Inc
2024/03/04	21 : 30	Business Wire	Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial	NASDAQ:NGNE	Neurogene Inc
2024/02/29	21 : 30	Business Wire	Neurogene to Participate in Upcoming Investor Conferences	NASDAQ:NGNE	Neurogene Inc
2024/01/16	21 : 00	Business Wire	Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer	NASDAQ:NGNE	Neurogene Inc
2024/01/05	21 : 00	Business Wire	Neurogene Announces Business Update and 2024 Outlook	NASDAQ:NGNE	Neurogene Inc

Showing the most relevant articles for your search:NASDAQ:NGNE

1

Vontobel Financial Produ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約